StockData

AdaptHealth vs Aveanna Healthcare

AHCO and AVAH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AHCO and AVAH compare

Aveanna Healthcare is the larger company, worth 3.6 times as much as AdaptHealth ($2.9B against $792M).

Aveanna Healthcare grew revenue faster over the last twelve months (19.5% versus 4.2% for AdaptHealth).

Aveanna Healthcare keeps more of each dollar of sales as profit, with a net margin of 10.6% compared with −7.1% at AdaptHealth.

Aveanna Healthcare scores higher on the StockData Score (11 against 6 for AdaptHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAHCOAVAH
Size and price
Market cap$792M$2.9B
Share price$5.81$13.16
Change, 1 year−36.6%33.5%
Change, 5 years−76.7%57.4%
Beta (5Y)0.771.41
Employees11K32K
StockData Score
Total score611 (better)
Valuation score33
Growth score03 (better)
Performance score04 (better)
Health score3 (better)1
Dividend score00
Valuation
P/E–10.7×
P/S0.2× (better)1.1×
P/B0.6× (better)10.0×
EV/EBITDA9.7× (better)14.3×
P/FCF8.1×–
FCF yield12.3%–
Fair value$12.98$22.07
Margin of safety55.2% (better)40.4%
Growth
Revenue growth (TTM)4.2%19.5% (better)
Revenue growth, 5Y average25.2% (better)10.2%
Net income growth (TTM)−383%1381% (better)
EPS growth (TTM)−419%1267% (better)
Profitability
Gross margin17.0%32.3% (better)
Operating margin−4.5%10.5% (better)
Net margin−7.1%10.6% (better)
FCF margin3.0%–
Return on equity−15.4%200% (better)
Return on invested capital−3.4%20.6% (better)
Financial health
Debt / equity1.37 (better)4.52
Net debt / EBITDA6.794.21 (better)
Interest coverage–2.2×
Current ratio1.121.16 (better)
Altman Z-score0.571.94 (better)
Piotroski F-score47 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions104%93.0%
Held by insiders14.7%16.9%
Insider net buying, 12 months$49.1M (better)−$782M
Short interest, % of float8.3%3.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.